Financial Highlights: ($ in millions, except per share amounts) | Three Months Ended | Nine Months Ended | ||||
2024 | 2023 | % Change | 2024 | 2023 | % Change | |
15% | 10% | |||||
Gross Margin | 63.9% | 63.9% | flat | 63.6% | 63.3% | +30 bps |
Operating Income | 22% | 3% | ||||
Operating Margin | 25.0% | 23.7% | +130 bps | 21.9% | 23.5% | (160 bps) |
Net Income attributable to IP | 17% | (1%) | ||||
Diluted EPS | 16% | (2%) | ||||
The average dollar/euro exchange rate for the 2024 third quarter was 1.10 compared to 1.09 in the 2023 third quarter, while for the first nine months of 2024, the average dollar/euro exchange rate was 1.09, compared to 1.08 in the first nine months of 2023, leading to a positive 0.4% and 0.2% foreign exchange impact for the third quarter and first nine months of 2024, respectively. |
Operational Commentary
“Third quarter sales in our three largest markets,
“Central and South America’s sales increased by 20% and
“During the summer months, we shipped initial orders for gift sets, resulting in successful sell-out and strong re-orders during the fall. Currently, our retail partners and distributors are replenished and well stocked in preparation for the holiday season. Historically, this program primarily catered to
Discussing the newest brands,
“We are looking forward to a good final quarter and record results for the year. We have already received excellent feedback from both distributors and retailers on our 2025 new product pipeline, which is especially reassuring given that the fragrance market, while still robust, has somewhat moderated. For next year, we are expecting a softer landing with more sustainable growth rates than in prior years.
“While we are always on the lookout for additional brand opportunities, our broad-based existing portfolio, along with our expertise in advertising and promotion, product development, market intelligence, and global distribution, should continue to fuel record results in the coming years.”
Financial Commentary
“SG&A expenses grew 12% in the third quarter, slightly below our sales increase of 15%, leading to a 130 basis point reduction from the prior year as a percentage of sales. On a year-to-date basis, SG&A expenses were up 16%, or 190 basis points as a percentage of sales. During the third quarter, our
“Once again, the amortization cost of the
“Our financial position remains strong with
Guidance
Initial full-year 2025 guidance is scheduled to be announced on
Dividend
The Company’s regular quarterly cash dividend of
Conference Call
Management will host a conference call to discuss financial results and business operations beginning at
Interested parties may participate in the live call by dialing:
International: (201) 493-6749
Participants are asked to dial-in approximately 10 minutes before the conference call is scheduled to begin.
A live audio webcast will also be available in the “Events” tab within the Investor Relations section of the Company’s website at www.interparfumsinc.com, or by clicking here. The conference call will be available for webcast replay for approximately 90 days following the live event.
About
Operating in the global fragrance business since 1982,
The portfolio of prestige brands includes Abercrombie & Fitch,
Forward-Looking Statements:
Statements in this release which are not historical in nature are forward-looking statements. Although we believe that our plans, intentions, and expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such plans, intentions, or expectations will be achieved. In some cases, you can identify forward-looking statements by forward-looking words such as "anticipate, "believe", "could", "estimate", "expect", "intend", "may", "should", "will", and "would" or similar words. You should not rely on forward-looking statements, because actual events or results may differ materially from those indicated by these forward-looking statements as a result of a number of important factors. These factors include, but are not limited to, the risks and uncertainties discussed under the headings “Forward Looking Statements” and "Risk Factors" in
Contact Information: | ||
or | ||
Chief Financial Officer | Investor Relations Counsel | |
(212) 983-2640 | (212) 836-9623 / kdaly@equityny.com | |
www.interparfumsinc.com | www.theequitygroup.com | |
See Accompanying Tables
CONSOLIDATED BALANCE SHEETS | ||||||||
(In thousands except share and per share data) | ||||||||
(Unaudited) | ||||||||
ASSETS | ||||||||
2024 | 2023 | |||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 78,419 | $ | 88,462 | ||||
Short-term investments | 78,783 | 94,304 | ||||||
Accounts receivable, net | 354,175 | 247,240 | ||||||
Inventories | 412,758 | 371,859 | ||||||
Receivables, other | 4,984 | 7,012 | ||||||
Other current assets | 26,788 | 29,458 | ||||||
Income taxes receivable | 533 | 691 | ||||||
Total current assets | 956,440 | 839,026 | ||||||
Property, equipment and leasehold improvements, net | 166,435 | 169,222 | ||||||
Right-of-use assets, net | 25,471 | 28,613 | ||||||
Trademarks, licenses and other intangible assets, net | 290,864 | 296,356 | ||||||
Deferred tax assets | 19,742 | 14,545 | ||||||
Other assets | 21,648 | 21,567 | ||||||
Total assets | $ | 1,480,600 | $ | 1,369,329 | ||||
LIABILITIES AND EQUITY | ||||||||
Current liabilities: | ||||||||
Loans payable - banks | $ | 8,957 | $ | 4,420 | ||||
Current portion of long-term debt | 44,538 | 29,587 | ||||||
Current portion of lease liabilities | 6,189 | 5,951 | ||||||
Accounts payable – trade | 96,578 | 97,409 | ||||||
Accrued expenses | 166,156 | 178,880 | ||||||
Income taxes payable | 17,164 | 8,498 | ||||||
Total current liabilities | 339,582 | 324,745 | ||||||
Long–term debt, less current portion | 134,585 | 127,897 | ||||||
Lease liabilities, less current portion | 21,304 | 24,517 | ||||||
Equity: | ||||||||
Preferred stock, | — | — | ||||||
Common stock, | 32 | 32 | ||||||
Additional paid-in capital | 101,123 | 98,565 | ||||||
Retained earnings | 762,826 | 693,848 | ||||||
Accumulated other comprehensive loss | (32,641 | ) | (40,188 | ) | ||||
(52,864 | ) | (52,864 | ) | |||||
778,476 | 699,393 | |||||||
Noncontrolling interest | 206,653 | 192,777 | ||||||
Total equity | 985,129 | 892,170 | ||||||
Total liabilities and equity | $ | 1,480,600 | $ | 1,369,329 |
CONSOLIDATED STATEMENTS OF INCOME | |||||||||||||||||
(In thousands except per share data) | |||||||||||||||||
(Unaudited) | |||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||
Net sales | $ | 424,629 | $ | 367,969 | $ | 1,090,821 | $ | 988,936 | |||||||||
Cost of sales | 153,469 | 132,962 | 396,519 | 362,568 | |||||||||||||
Gross margin | 271,160 | 235,007 | 694,302 | 626,368 | |||||||||||||
Selling, general and administrative expenses | 165,166 | 147,805 | 455,506 | 393,866 | |||||||||||||
Income from operations | 105,994 | 87,202 | 238,796 | 232,502 | |||||||||||||
Other expenses (income): | |||||||||||||||||
Interest expense | 1,978 | 2,397 | 5,726 | 7,030 | |||||||||||||
Loss (gain) on foreign currency | 3,355 | (669 | ) | 3,085 | (656 | ) | |||||||||||
Interest and investment loss (income) | 254 | (1,062 | ) | (1,690 | ) | (8,421 | ) | ||||||||||
Other loss (income) | 1 | (77 | ) | (35 | ) | (125 | ) | ||||||||||
5,588 | 589 | 7,086 | (2,172 | ) | |||||||||||||
Income before income taxes | 100,406 | 86,613 | 231,710 | 234,674 | |||||||||||||
Income taxes | 23,571 | 20,493 | 54,974 | 55,128 | |||||||||||||
Net income | 76,835 | 66,120 | 176,736 | 179,546 | |||||||||||||
Less: Net income attributable to the noncontrolling interest | 14,576 | 12,906 | 36,606 | 37,312 | |||||||||||||
Net income attributable to | $ | 62,259 | $ | 53,214 | $ | 140,130 | $ | 142,234 | |||||||||
Earnings per share: | |||||||||||||||||
Net income attributable to | |||||||||||||||||
Basic | $ | 1.94 | $ | 1.66 | $ | 4.37 | $ | 4.44 | |||||||||
Diluted | $ | 1.93 | $ | 1.66 | $ | 4.34 | $ | 4.42 | |||||||||
Weighted average number of shares outstanding: | |||||||||||||||||
Basic | 32,026 | 31,976 | 32,030 | 32,000 | |||||||||||||
Diluted | 32,266 | 32,124 | 32,266 | 32,149 | |||||||||||||
Dividends declared per share | $ | 0.750 | $ | 0.625 | $ | 2.250 | $ | 1.875 | |||||||||
Source:
2024 GlobeNewswire, Inc., source